125 related articles for article (PubMed ID: 2572262)
21. Effects of the partial beta 1-adrenergic agonist, xamoterol, on hemodynamics and regional myocardial function during acute coronary occlusion in dogs.
Miura T; Matsuzaki M; Toma Y; Yonezawa F; Kohno M; Katayama K; Ozaki M; Kumada T; Kusukawa R
J Cardiovasc Pharmacol; 1990 Feb; 15(2):182-7. PubMed ID: 1689411
[TBL] [Abstract][Full Text] [Related]
22. Xamoterol: stabilising the cardiac beta receptor?
Lancet; 1988 Dec; 2(8625):1401-2. PubMed ID: 2904527
[No Abstract] [Full Text] [Related]
23. Old and new inotropic drugs.
Carlier J; el Allaf D
Resuscitation; 1984 Mar; 11(3-4):217-31. PubMed ID: 6144152
[TBL] [Abstract][Full Text] [Related]
24. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
Manders WT; Vatner SF; Braunwald E
J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
[TBL] [Abstract][Full Text] [Related]
25. Effect of xamoterol on peripheral blood vessels in healthy subjects.
Fitzgerald DE
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):70S-72S. PubMed ID: 2572259
[TBL] [Abstract][Full Text] [Related]
26. Effects of prenalterol and its N-homoveratryl derivative in the anaesthetized cat.
Maccarrone C; Malta E; Raper C
Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):245-50. PubMed ID: 6621718
[No Abstract] [Full Text] [Related]
27. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
Fitzgerald DE; Harry JD
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
[TBL] [Abstract][Full Text] [Related]
28. Sino-aortic denervation causes right atrial beta adrenoceptor down-regulation.
Zanesco A; Spadari-Bratfisch RC; Barker LA
J Pharmacol Exp Ther; 1997 Feb; 280(2):677-85. PubMed ID: 9023279
[TBL] [Abstract][Full Text] [Related]
29. The inhibitory GTP-binding protein (Gi) regulates the agonistic property of beta-adrenergic ligands in isolated rat adipocytes. Evidence for a priming effect of cyclic AMP.
Wesslau C; Smith U
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):41-6. PubMed ID: 1280115
[TBL] [Abstract][Full Text] [Related]
30. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
Lammers JW; Müller ME; Folgering HT; van Herwaarden CL
Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680
[TBL] [Abstract][Full Text] [Related]
31. The partial agonist activity of xamoterol (ICI 118,587) studied by heart rate response in pithed rats.
Hashimoto T; Kondo K; Shiina A; Toyo-Oka T; Kawasaki K; Kimura K; Hosoda S
Jpn Circ J; 1988 Jan; 52(1):60-5. PubMed ID: 2896255
[TBL] [Abstract][Full Text] [Related]
32. [Effects of xamoterol in moderate cardiac insufficiency].
Kayanakis JG; Larouchi L; Doat P; Grenet B; Fauvel JM; Bounhoure JP
Presse Med; 1989 Apr; 18(13):667-70. PubMed ID: 2566161
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the effects of xamoterol and isoprenaline on rat cardiac beta-adrenoceptors: studies of function and regulation.
Kowalski MT; Haworth D; Lu X; Thomson DS; Barnett DB
Br J Pharmacol; 1990 Jan; 99(1):27-30. PubMed ID: 2158836
[TBL] [Abstract][Full Text] [Related]
34. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
35. Xamoterol, a new selective beta-1-adrenoceptor partial agonist, in the treatment of postural hypotension.
Mehlsen J; Trap-Jensen J
Acta Med Scand; 1986; 219(2):173-7. PubMed ID: 2870611
[TBL] [Abstract][Full Text] [Related]
36. Cardioselectivity, kinetics, hemodynamics, and metabolic effects of xamoterol.
Jennings G; Bobik A; Oddie C; Restall R
Clin Pharmacol Ther; 1984 May; 35(5):594-603. PubMed ID: 6143634
[TBL] [Abstract][Full Text] [Related]
37. Cardiac beta-adrenoceptor regulation and the effects of partial agonism.
Barnett DB; Lu XY
Am J Cardiol; 1991 May; 67(12):18C-19C. PubMed ID: 1673585
[TBL] [Abstract][Full Text] [Related]
38. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant.
Strosberg AM
Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864
[TBL] [Abstract][Full Text] [Related]
39. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.
Hashimoto T; Shiina A; Toyo-Oka T; Hosoda S; Kondo K
Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751
[TBL] [Abstract][Full Text] [Related]
40. Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.
Cambridge D; Whiting MV; Allan G
Br J Pharmacol; 1988 Jan; 93(1):165-75. PubMed ID: 2894874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
